{"count":4,"index":{"built_at":"2026-07-27T23:33:40.856410+00:00","public_records":55311,"revision":"2965aee17465f8a8f5f001f7"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: hsCRP in the context of Wechseljahre"},"results":[{"answer":"An hsCRP level above 3.0 mg/L indicates elevated cardiovascular risk due to systemic inflammation. During menopause (perimenopause and postmenopause), the natural decline in estrogen can increase inflammatory activity and potentially raise hsCRP. However, hsCRP is a non-specific marker: acute infections, injuries, or chronic inflammatory conditions (e.g., rheumatoid arthritis) must be ruled out before interpreting the result. The evidence here is based on clinical practice, not on menopause-specific studies. Lifestyle interventions—such as a balanced diet, regular exercise, and weight management—are the primary strategies to lower elevated hsCRP. A comprehensive cardiovascular risk assessment (including lipid profile, blood pressure, and fasting glucose) is essential. Hormone therapy may affect hsCRP levels but is not recommended solely for cardiovascular prevention. Caveat: repeat testing and clinical context are needed, as hsCRP can fluctuate significantly.","area":"gesundheit","canonical_id":"gesundheit:canonical-13bd117a61e8159f5f9b9aa5","id":"public-d3f2aec9d5b9504e952e7414","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: hsCRP in the context of Wechseljahre","score":24.12802622,"snippet":"An hsCRP level above 3.0 mg/L indicates elevated cardiovascular risk due to systemic inflammation. During menopause (perimenopause and postmenopause), the natural decline in estrogen can increase inflammatory activity and potentially raise hsCRP. However, hsCRP is a non-specific marker: acute infections, injuries, or chronic inflammatory conditions (e.g., rheumatoid arthritis) must be ruled out before interpreting the result. The evidence here is based on clinical practice, not on menopause-specific studies. Lifestyle interventions—such as a balanced diet, regular exercise, and weight management—are the primary strategies to lower elevated hsCRP. A comprehensive cardiovascular risk assessmen","sources":[],"title":"Evidence check: hsCRP in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d3f2aec9d5b9504e952e7414/evidence-check-hscrp-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Evidence for DNA metabolism tests in menopause is weak to moderate. While some gene variants (e.g., FTO, GHRL) show small associations with weight and appetite, effects are modest and strongly modified by lifestyle, hormonal changes, and diet. Menopause itself alters metabolism due to estrogen decline, so a genetic test adds limited predictive value. Direct-to-consumer tests often overstate clinical relevance. MyBody-X is not a medical diagnostic. Focus on evidence-based lifestyle: protein-rich diet, resistance training, sleep hygiene, and stress management. Blood markers like fasting insulin, HbA1c, or hsCRP may be more actionable. Evidence: human-observational/GWAS, not menopause-specific. Beware of exaggerated claims.","area":"gesundheit","canonical_id":"gesundheit:canonical-a0d5038e43d794b9c5262aa8","id":"public-e3decfa21a5f2c5edf66e040","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: DNA Stoffwechseltest in the context of Wechseljahre","score":22.2795538,"snippet":"Evidence for DNA metabolism tests in menopause is weak to moderate. While some gene variants (e.g., FTO, GHRL) show small associations with weight and appetite, effects are modest and strongly modified by lifestyle, hormonal changes, and diet. Menopause itself alters metabolism due to estrogen decline, so a genetic test adds limited predictive value. Direct-to-consumer tests often overstate clinical relevance. MyBody-X is not a medical diagnostic. Focus on evidence-based lifestyle: protein-rich diet, resistance training, sleep hygiene, and stress management. Blood markers like fasting insulin, HbA1c, or hsCRP may be more actionable. Evidence: human-observational/GWAS, not menopause-specific.","sources":[],"title":"Evidence check: DNA Stoffwechseltest in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e3decfa21a5f2c5edf66e040/evidence-check-dna-stoffwechseltest-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":22.0827429,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of glucose in menopause is not directly addressed in the provided context. It is well established that hormonal changes during menopause—especially declining estrogen—can reduce insulin sensitivity, leading to higher blood glucose levels and increased risk of metabolic syndrome. MyBody-X tests like the Cardio Risk Check measure lipids and hsCRP but not glucose or insulin resistance directly. A DNA test might identify genetic variants related to glucose metabolism, but effect sizes are small and not diagnostic. Without specific studies from the context, the evidence is unclear. Women in menopause should monitor fasting glucose and HbA1c with their physician. Caveat: No home test replaces clinical evaluation.","area":"gesundheit","canonical_id":"gesundheit:canonical-829fd3a8072fc6e139d17020","id":"public-cd47ac88a62415d60fc5ebff","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Glukose play in Wechseljahre?","score":21.13578392,"snippet":"The role of glucose in menopause is not directly addressed in the provided context. It is well established that hormonal changes during menopause—especially declining estrogen—can reduce insulin sensitivity, leading to higher blood glucose levels and increased risk of metabolic syndrome. MyBody-X tests like the Cardio Risk Check measure lipids and hsCRP but not glucose or insulin resistance directly. A DNA test might identify genetic variants related to glucose metabolism, but effect sizes are small and not diagnostic. Without specific studies from the context, the evidence is unclear. Women in menopause should monitor fasting glucose and HbA1c with their physician. Caveat: No home test repl","sources":[],"title":"What role does Glukose play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-cd47ac88a62415d60fc5ebff/what-role-does-glukose-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}